Recall Radar
All recallsMedicine & devices

Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873,…

Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.

Class II Medicine & devices FDA March 25, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
SOMERSET THERAPEUTICS LLC — Somerset, NJ
Severity
Class II — moderate
Reported
March 25, 2026
Quantity
62190 vials
Recall number
D-0398-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide in the USA

Other medicine & devices recalls

See every current recall on the live dashboard →